ClinicalTrials.gg
RecruitingNCT06460909PrePS HVUpdated Jun 14, 2024

Randomised Study Evaluating the Interest of Psychological Support of Patients Waiting for Hallux Valgus Surgery

An interventional study of Psychological support in Hallux Valgus Surgery, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-14.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Nov 2024, 2 years ago, but the record still lists the study as recruiting.
  • Registered 1 year 3 months after the study started (first participant enrolled Feb 2023, registered May 2024).
  • Started Feb 2023; still recruiting 3 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 17 studies in Hallux Valgus with a site in France — 3 open to participants now, 5 under way, none of them phase 3. Hallux Valgus · France.

Planned enrollment
4th of 13
180 · median 74
Started
2023
the only one that year
No phase
13 of 17
3 open now
Registered
15th of 17
by date
Lead sponsor
2 of 17
Assistance Publique - Hôpitaux de Paris

Among the 17 studies in Hallux Valgus with a site in France, this one is the 4th largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2023, is one of 13 with no phase, and was the 15th registered.

Hallux Valgus

157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.

This study's planned enrollment of 180 is above the median of 58 across 119 interventional studies indexed under Hallux Valgus.

Browse Hallux Valgus studies →

Open to participants now

3 of the 17 studies in Hallux Valgus with a site in France are open now, in 1 country. Each count lists the studies.

All 3 open studies →

Where they have run

Who these studies take

Of the 21 Hallux Valgus studies recruiting now, 10 (48%) set no upper age limit and 7 (33%) stop at 75 or younger; 3 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Hallux Valgus with a site in France, or all of them as a file.
02

Study summary

Catastrophizing is a negative evaluation of events. What surgery concerns, pain catastrophizing is one of the main risks of postoperative pain and / or poor functional recovery. The best survey to evaluate pain catastrophizing is the PCS (Pain Catastrophizing Scale). According to the authors, catastrophizers report more negative pain related thoughts, more emotional distress and more pain than non-catastrophizers. The PCS is a significant predictor of pain intensity and so of poor functional recovery.

It is already well known that anxiety and catastrophizing predict postoperative pain.

The actual studies focus mainly on functional recovery of knee and hip arthroplasties, but less on pain and functional recovery of hallux valgus surgery.

According to several authors, adapted psychological support of preoperative catastrophizing could allow a better postoperative evolution.

Our hypothesis is that a preoperative psychological consultation of catastrophizing patients is efficient to lower pain catastrophizing in adult patients undergoing a surgical operation for hallux valgus.

The first objective is to evaluate the impact of a psychological support of preoperative pain catastrophizing during a hallux valgus surgery.The principal evaluation scale is the pain catastrophizing score before and after surgery.

The second objective is to evaluate the pain and functional recovery of pain catastrophizing patients. The criteria of this survey are: anxiety score (usual and actual), pain and function according to the FAOS (Foot and Ankle Outcome Score) pain (Analogic Visual Scale).

03

Conditions studied

  • Hallux Valgus Surgery

Browse trials for

Keywords

  • Hallux Valgus Surgery
  • Psychological Support
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult over 18
  • Independent, living in its own home
  • Affiliated at a social security
  • Consent signed
  • Waiting for a Hallux Valgus surgery.

Exclusion criteria

Exclusion Criteria:

  • Not Able to understand french language
  • Patient refusal
  • Under guardianship
  • Under french AME system
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Psychological support arm

    Patients randomized with psychological intervention.

    Other: Psychological support

  • No intervention
    Without support

    Patients with routine care with psychological support.

Interventions

  • OtherPsychological support

    An interview with the psychologist before surgery.

06

What researchers measure

Primary outcomes

  1. Impact of preoperative psychological support on pain catastrophizing

    By State portion of the Spielberger State-Trait Anxiety Inventory STAI.

    Time frame: at baseline

Secondary outcomes

  1. Pain evaluate of catastrophizing patients

    By American Orthopaedic Foot and Ankle Society (AOFAS).

    Time frame: at baseline

07

Study locations

1 of 1 sites recruiting
  • Orthopedia and traumatological department
    Boulogne-Billancourt, 92100, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2023 (actual). Primary completion is estimated for Nov 2024, 21 months after the start.

Of 51 non-industry interventional studies with no phase under Hallux Valgus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 55. This study's planned 21 months is below that.

Counting every sponsor, half of 56 studies reached it within 26 months; a quarter within 11 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2024
First posted
Jun 14, 2024
StartActual
Feb 2, 2023
Primary completionEst.
Nov 2, 2024
CompletionEst.
Feb 2, 2025
Last update
Jun 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06460909
Responsible party
Sponsor
First posted
Jun 14, 2024
Start date
Feb 2, 2023
Primary completion
Nov 2, 2024 (estimated)
Completion
Feb 2, 2025 (estimated)
Last update
Jun 14, 2024

Study contacts

Marie-Hélène SANDIFORD
Contact
mh.sandiford@gmail.com
+33662148018
Alexandre Hardy, MD
Contact
alex.hardy.1@gmail.com
+33615101016
Marie-Hélène Sandiford
principal investigator · Ambroise Paré hospital - APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion